SYNERGISTIC EFFECT OF MACUNA PRURIENS AND CURCUMA LONGA IN ROTENONE INDUCED PARKINSON DISEASED ANIMAL MODEL
DOI:
https://doi.org/10.22159/ajpcr.2025v18i6.54421Keywords:
Macuna pruriens, Curcuma longa, Parkinson’s diseaseAbstract
Objectives: Parkinson’s disease (PD) is a brain disorder that causes unintended or uncontrollable movements, such as shaking, stiffness, and difficulty with balance and coordination. Symptoms usually begin gradually and worsen over time. As the disease progresses, people may have difficulty walking and talking. Recently, several herbal medicines have been tried for the treatment of such neurogenerative disorders. Studies on the extract of Macuna pruriens (MP) seeds and Curcuma longa (CL) rhizome have been done for better management of Parkinson’s disease.
Methods: The combine effect of extracts of these herbs is studied on rotenone-induced PD on animal model. Both the plants were authenticated. Extracts of MP seeds and CL rhizome were prepared. These extracts were administered into rats to evaluate anti Parkinson’s activity. It was included with the catalepsy test, rota rod test, open field test, and estimation of dopamine in the brain.
Results: The number of crossings was increased to 91.43±8.3 after the 28th of administration of both the extracts together. It is much higher than disease control and individual administration of extracts. After 28 days of animal study, attenuation of catalepsy behavior to 6.67±0.7 s was found with co-administration of both the extracts. The degree of prevention of fall-off time was much higher and significant on the 28th day of treatment, with 185.3±12.9 s in the groups treated with intranasal administration of the combination of both the extracts. The intranasal treatment with both the extracts elicited significantly higher elevation of brain dopamine content compared to the disease control group.
Conclusion: This result showed that the Mp and Cl combination may be useful for better management of PD.
Downloads
References
Palma JA, Kaufmann H. Treatment of autonomic dysfunction in Parkinson disease and other synucleinopathies. Mov Disord.
;33(3):372-90. doi: 10.1002/mds.27344, PMID 29508455
Buyan-Dent L, Mangin T, Shannon K. Pharmaceutical treatment of Parkinson’s disease the best outcomes rely on a handful of medicines and partnership among clinicians, patients, and caregivers. In: Practical Neurology. United States: Wolters Kluwer Health; 2018.
Kamkaen N, Chittasupho C, Vorarat S, Tadtong S, Phrompittayarat W, Okonogi S, et al. Mucuna pruriens seed aqueous extract improved neuroprotective and acetylcholinesterase inhibitory effects compared with synthetic L-dopa. Molecules. 2022 May 13;27(10):3131. doi: 10.3390/molecules27103131, PMID 35630617
Caronni S, Del Sorbo F, Barichella M, Fothergill-Misbah N, Denne T, Laguna J, et al. Mucuna pruriens to treat Parkinson’s disease in low-income countries: Recommendations and practical guidelines from the farmer to clinical trials. Paving the way for future use in clinical practice. Parkinsonism Relat Disord. 2024;124:106983. doi: 10.1016/j. parkreldis.2024.106983, PMID 38797572
Theansungnoen T, Nitthikan N, Wilai M, Chaiwut P, Kiattisin K, Intharuksa A. Phytochemical analysis and antioxidant, antimicrobial, and antiaging activities of ethanolic seed extracts of four Mucuna species. Cosmetics. 2022;9(1):14.
Patel A, Olang CA, Lewis G, Mandalaneni K, Anand N, Gorantla VR. An overview of Parkinson’s disease: Curcumin as a possible alternative treatment. Cureus. 2022 May 15;14(5):e25032. doi: 10.7759/ cureus.25032, PMID 35719816
Dehzad MJ, Ghalandari H, Nouri M, Askarpour M. Antioxidant and anti-inflammatory effects of curcumin/turmeric supplementation in adults: AGRADE-assessed systematic review and dose-response meta-analysis of randomized controlled trials. Cytokine 2023;164:156144.
Ciuca MD, Racovita RC. Curcumin: Overview of extraction methods, health benefits, and encapsulation and delivery using microemulsions and nanoemulsions. Int J Mol Sci. 2023 May 17;24(10):8874. doi: 10.3390/ijms24108874, PMID 37240220
Mainum SH, Shashikala P. Extraction, nanoformulation and evaluation of curcumin. Int J Pharmacogn. 2014;1(8):520-7.
Sharma N, Khurana N, Muthuraman A, Utreja P. Pharmacological evaluation of vanillic acid in rotenone-induced Parkinson’s disease rat model. Eur J Pharmacol. 2021;903:174112. doi: 10.1016/j. ejphar.2021.174112, PMID 33901458
Dovonou A, Bolduc C, Soto Linan VS, Gora C, Peralta MR, Lévesque M. Animal models of Parkinson’s disease: Bridging the gap between disease hallmarks and research questions. Transl Neurodegener. 2023;12(1):36. doi: 10.1186/s40035-023-00368-8, PMID 37468944
Mishra M, Sonar PK, Tripathi AC, Saraf SK, Verma SK. Ligand and structure-based hybrid screening for anti-Parkinson agents and their pharmacological evaluation. Int J Pharm Educ Res. 2020;2(2):30-8. doi: 10.37021/ijper.v2i2.1
Waku I, Magalhães MS, Alves CO, De Oliveira AR. Haloperidol-induced catalepsy as an animal model for parkinsonism: A systematic review of experimental studies. Eur J Neurosci. 2021;53(11):3743-67. doi: 10.1111/ejn.15222, PMID 33818841
Leem YH, Park JS, Park JE, Kim DY, Kim HS. Walking exercise in subventricular zone, subgranular zone, and Neurogenic effects of rotarod substantia nigra in MPTP-induced Parkinson’s disease mice. Sci Rep. 2022;12(1):10544. doi: 10.1038/s41598-022-14823-5, PMID 35732806
Lama J, Buhidma Y, Fletcher EJ, Duty S. Animal models of Parkinson’s disease: A guide to selecting the optimal model for your research. Neuronal Signal. 2021;5:NS20210026.
Khanam M. A review on the phytopharmacological properties, unani and modern pharmacology of Bisfayej (Polypodium vulgare Linn). Int J Pharm Pharm Sci. 2023;15:16-20.
Varier KM, Thangarajan S, Chinnasamy A. Effect of imperatorin in neuropathology of Parkinson’s disease: An in silico study. Int J Pharm Clin Res. 2017;9(8):599-609.
Published
How to Cite
Issue
Section
Copyright (c) 2025 Mr.Aniruddha Kulkarni, Dr. Manoj Tare, Dr. Meera Singh
This work is licensed under a Creative Commons Attribution 4.0 International License.
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.
